WithdrawnNot applicableNCT00508313

Thermal Signature of Patients Undergoing Radiation Therapy

The goal of this clinical research study is to evaluate whether thermal imaging (recording body temperature) can be used to check the body's response to cancer therapy. Primary Objective: * The primary objective of this study is to establish techniques and methodologies of quantifying thermal signatures and their changes for cancer patients undergoing chemoradiation therapy. Secondary Objective: * The secondary objective is to evaluate correspondence between changes of thermal signature of a normal organ, e.g. lung or esophagus, versus the toxicity of that organ from chemoradiation therapy.

Checked against the public recordLast updated Apr 8, 2016 · Source: ClinicalTrials.gov

StatusWithdrawn
PhaseNot applicable
U.S. locations1
SponsorM.D. Anderson Cancer Center
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
M.D. Anderson Cancer Center
Interventions being studied
Procedure: Thermal Imaging
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
03
Public criteria

Who may be able to participate

Inclusion Criteria: 1. Patients with lung cancers of any stages. 2. Patients will undergo chemotherapy or radiation therapy. 3. Patients with KPS \> 70, are physically mobile and independent, and are able to stand still straight for more than 10 minutes for imaging purposes. 4. Age \>18 years Exclusion Criteria: 1. Patients who had lung surgery within past 3 months. 2. Patients with breast implant or cardiac implant (pace maker or defibrillator). 3. Patients who had skin diseases (e.g. skin desquamation, dermatitis) or other medical conditions that may interfere with thermal measurement. 4. Pregnant woman 5. Extreme obese patients with body mass index \>=35

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • U.T.M.D. Anderson Cancer CenterHouston, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 8, 2016. Always confirm current availability with the study team.

View original record ↗